This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Original Article -
Expression of a novel beta adaptin subunit mRNA splice
variant in human testes
Xin-Dong Zhang, Lan-Lan Yin, Ying Zheng, Li Lu, Zuo-Min Zhou, Jia-Hao Sha
Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 210029, China
Abstract
Aim: To identify a novel isoform of adaptin 2
beta subunit (named Ap2¦Â-NY) and to investigate its relationship with
testicular development and spermatogenesis. Methods: Using a human testis cDNA microarray, a clone
(Ap2¦Â-NY), which was strongly expressed in adult testes but weakly expressed in embryo testes, was sequenced and analyzed.
Using polymerase chain reaction (PCR), the tissue distribution and expression time pattern of
Ap2¦Â-NY were determined. Results: Ap2¦Â-NY was identified and has been deposited in the GenBank (AY341427). The expression level of
Ap2¦Â-NY in the adult testis was about 3-fold higher than that in the embryo testis. PCR analysis using multi-tissue cDNA
indicated that Ap2¦Â-NY was highly expressed in the testis, spleen, thymus, prostate, ovary, blood leukocyte and brain,
but not in the heart, placenta, lung, liver, skeletal muscle, kidney and pancreas. In addition,
Ap2¦Â-NY was variably expressed in the testes of patients with spermatogenesis-disturbance and spermatogenesis-arrest but not expressed in
those of Sertoli-cell-only syndrome, which implied that, in the testis,
Ap2¦Â-NY was restrictively expressed in germ cells. Conclusion: Ap2¦Â-NY is an isoform of
Ap2¦Â and may be involved in regulating the process of spermatogenesis
and testis development. (Asian J Androl 2005 Jun; 7: 179-188)
Keywords: alternative splicing; adaptin beta subunit; spermatogenesis
Correspondence to: Dr Jia-Hao Sha, Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 210029, China.
Tel/Fax: +86-25-8686-2908
E-mail: shajh@njmu.edu.cn
Received 2004-08-11 Accepted 2004-12-09
DOI: 10.1111/j.1745-7262.2005.00025.x
1 Introduction
Adaptin 2 beta subunit (Ap2¦Â-NY) is a part of the
adaptin protein 2 (AP2) coat assembly protein complex
which links clathrin to receptors in the coated vesicles
[1]. Previously, the AP2 adaptor was reported as a
complex composed of two large ~110 kDa subunits (and
¦Â2), one medium ~50 kDa subunit (¦Ì2) and one small
~17 kDa subunit (s2) [2, 3]. Each large subunit can be
divided into a 60-70 kDa trunk domain separated from a
25-30 kDa appendage domain (sometimes referred to as
an "ear" domain) by a ~100-residue, protease-sensitive
linker [4]. AP2 links the endocytic cargo (ligand and
receptor) to the clathrin coat and the internalization
occurs through forming clathrin-coated vesicles (CCVS).
The a subunit interacts with CCV formation regulatory
protein or accessory proteins such as AP180, auxilin,
amphiphysin, eps15 and epsin via its appendage domain
[5, 6]. The ¦Â2 subunit binds to clathrin via the canonical
clathrin box motif (LFxFD/E, where F is a bulky hydrophobic amino acid and x represents any amino acid)
[7, 8] in its linker or hinge region [9]. In addition, AP2
adaptor binds to the short linear internalization motifs on cargo molecules, YxxF via the m2 subunit [10, 11] and
D/ExxxLL probably via the ¦Â2 trunk domain [12]. It was
confirmed by Yao et al. that AP2/transforming growth
factor beta (TGF-¦Â) receptor binding was mediated by
a direct interaction between the ¦Â2 subunit N-terminal
trunk domain and the cytoplasmic tails of the receptors
[13]. AP2 adaptor is one of the intriguing proteins
playing central roles in clathrin-mediated endocytosis.
Clathrin-mediated endocytosis is involved in many
cellular processes including the internalization and subsequent
down-regulation of activated growth factor receptors,
regulating the number and type of small molecule receptors, channels and transporters in the plasma
membrane, recycling of synaptic vesicles and the
maintenance of membrane identity.
On the basis of the adult testis cDNA microarrays
prepared by this laboratory, we compared the genes
expressed in the adult testis and embryo testis at a high
throughput [14]. Here we report a gene coding a novel
isoform of adaptin 2¦Â subunit (Ap2¦Â), named
Ap2¦Â-NY. The structure analysis results and distribution pattern of
Ap2¦Â-NY in the testis indicated its presumable functions
in the regulation of testicular development and
spermatogenesis by affecting protein transportation through CCV
conformation changing.
2 Materials and methods
2.1 Construction of human cDNA microarrays
A total of 9216 positive phage clones were picked
out randomly from Human Testis Insert l phage cDNA
library (clontech, Hl5503U) and amplified by po;ymerase
chain reaction (PCR). Then the PCR products were
spotted on the nylon membrane to make human testis cDNA
microarray. Protocol for cDNA microarray preparation
has been described in detail recently [14].
2.2 Array scanning and analyzing clones of interest
After being hybridized with the 33P-labeled embryo
testis and adult testis cDNA probes respectively, the
arrays were scanned and read out using the array gauge
software (Fuji Photo Film, Tokyo, Japan). After
subtraction of background, clones with intensities >10 were
considered positive signals. Then interested clones were
sequenced using the ABI 377 automatic sequencing
machine and analyzed (see also in Sha et
al. and Wang et al. [14, 15] ).
2.3 Multiple tissue distribution of
Ap2¦Â-NY
To determine the tissue distribution of
Ap2¦Â-NY, specific primers overlapping an intron were designed
to amplify cDNAs from sixteen kinds of human tissues (heart, brain, placenta, lung, liver, skeletal
muscle, kidney, pancreas, spleen, thymus, prostate,
testis, ovary, small intestine, colon and blood leukocytes), purchased from Clontech (K1420-1 and
K1421-1). The primers specific to Ap2¦Â-NY were as
following: P1 5' GACCATCTATCTAAGGAGTTG 3 ' and P2 5' TTGTCTACCCGGATGCAC 3'. The PCR
products (255 bp) of sixteen tissues were resolved by
electrophoresis on 1 % agarose gel and transferred to
Hybond-N+ nylon membrane (Amersham Pharmacia Biotech,
Little Chalfont, Buckinghamshire, UK).
The Ap2¦Â-NY cDNA probe was generated with the
same primers used for the PCR. The template was
Ap2¦Â-NY clone plasmid, and digoxigenin (Dig)-labeled dNTPs
were used (Dig DNA Labeling Mix; Roche Diagnostics,
Indianapolis, USA). The reaction protocol was as following: 35 cycles of 94
¡æ for 30 sec, 44 ¡æ for 30 sec and 72
¡æ for 60 sec. Hybridization was performed according to the Instruction Manual of Roche (DIG High
Prime DNA Labeling and Detection Starter Kit II,
Cat.No.1585614). After hybridization, the membrane was
incubated with alkaline phosphatase (Ap)-conjugated
anti-DIG antibodies and visualized with immunological
detection through chemiluminescent substrate for alkaline
phosphatase (CSPD; Roche). Human ¦Â-actin was used
as the positive control and the primers used were: P3
5'CGGTTGGCCTTGGGGTTCAGGGGG 3' and P4 5' ATCGTGGGGGCGCCCCAGGCACCA 3'.
2.4 Expressional state in a different development stage
and in patients of abnormal spermatogenesis
Human adult (37 years) and aged (73 years) testes
were obtained from the Body Donor Center (Nanjing
Medical University). Embryo testes were from
accidentally aborted 6-month fetuses. Human ejaculates were
obtained from healthy volunteers of proven fertility and
of normal semen quality as assessed by WHO criteria
(1999). Samples of patient testes were obtained via
biopsy from 12 infertile men at the First Affiliated Hospital
of Nanjing Medical University (Nanjing, China). The
clinical diagnoses based on testicular biopsy were
Sertoli-cell-only Syndrome (SCOS), spermatogenesis-arrest at
different stages and spermatogenesis-disturbance, each
[Internet]. S. Knudsen. Bioinformatics: 15, 356-361;
[cited 22 February 2005]. Available from:
http://www.cbs.dtu.dk/services/Promoter/).
3 Results
3.1 cDNA microarray hybridization
After hybridization and data analysis, genes
differentially expressed in human adult and embryo testes were
considered as testicular development and
spermatogenesis-related. Among those, a novel alternative splicing
form of Ap2¦Â was identified. The hybridization intensity
of Ap2¦Â-NY in the adult testis and embryo testis was
140.22 and 38.73, respectively (Figure 1). Obviously,
Ap2¦Â-NY was expressed both in the adult and embryo
testis, but the expression level in the adult testis was
approximately 3-fold more than that in the embryo testis.
3.2 Sequence identification and analysis of the
Ap2¦Â-NY gene
The full nucleotide and putative amino acid sequences
of Ap2¦Â-NY are displayed in Figure 2. The 3457 bp
Ap2¦Â-NY cDNA contains a complete open reading frame
(ORF) of 2642 bp with a methionine start codon at the
position 396 and a TGA stop codon at the position 3038.
The first start codon is preceded by an in-frame stop
codon TAA at position 354, suggesting that ATG at
position 396 is the start codon for the Ap2¦Â-NY protein.
Ap2¦Â-NY encoded an 880-amino acids protein with predicted
molecular weight of 98.12 kDa and isoelectric
point, 5.01. In addition, two different promoters, located at
-2300 and -1200 respectively, were found upstream in
the sequence by use of Promoter 2.0 (Promoter 2.0
matogenic disturbance and spermatogenesis-arrest (Figure 7). It is well known that in SCOS, there is no
germ cell but only Sertoli cells in the seminiferous tubules.
Therefore, Ap2¦Â-NY was not expressed in Sertoli cells
and Leydig cells, but in spermatogenic cells.
Figure 2. Nucleic acid and deduced amino acid sequences of the cDNA for Ap2?NY. Underlining shows PCR primers for the determination of expression profile. Upstream primer is located in the specific region of Ap2?NY. Downstream primer is homologous with that of other genes of the Ap2¦Âfamily. Initiation and stop codons are in italic type.
3.3 Homologous analysis of Ap2¦Â-NY and Ap2¦Â
A Basic local alignment search tool (BLAST) search in the human genome database localized the Ap2¦Â-NY gene to 17q11.2-q12. BLAST-nr showed Ap2¦Â-NY had a marked similarity to Ap2¦Â (Figure 3). The former has a distinct 5-UTR and it is 57 amino acids shorter than the latter at the amino terminus. The Simple Modular Architecture Research Tool (SMART) (SMART [Internet]. Schultz J, Proc Natl Acad Sci, 95(11):5857-64, USA; [cited 22 February 2005] Available from: http://smart.embl-heidelberg.de/) results showed that both genes have an adaptin N, a low complexity and an adaptin C motif, but the adaptin N motif of Ap2¦Â-NY is shorter than that of Ap2¦Â. Protein composition analysis, using Gene Runner software (http://www.generunner.com), indicates that the deleted region is hydrophilic and is most likely exposed on the protein surface (Figure 4).
3.4 Tissue distribution of Ap2¦Â-NY
The results of multiple tissue PCR and hybridization indicate that Ap2¦Â-NY is expressed in several human tissues (Figure 5). It is highly expressed in the spleen, thymus, prostate, testis, ovary, blood leukocyte and brain, but not in the heart, placenta, lung, liver, skeletal muscle, kidney and pancreas.
3.5 Development-dependent expression
RT-PCR results show that Ap2¦Â is strongly expressed in embryo, adult and aged testes (throughout the development stage of testis) while its expression level in spermatozoa is relatively lower (Figure 6). On the contrary, in spermatozoa and adult testes, Ap2¦Â-NY has higher expression level, while it is poorly expressed in embryos and old testes. This expressional profile validates the microarray result at the same time. Together all these evidences support the concept that different splicing isoform of Ap2¦Â-NY are predominant in various testis developmental stages and Ap2¦Â-NY may be involved in testis development and spermatogenesis.
3.6 Ap2¦Â-NY expression in infertile patient testes
The results of RT-PCR reveal that Ap2¦Â-NY was not expressed in patients with Sertoli-cell-only syndrome (SCOS) and was variably expressed in those with sper
in four patients. All the samples were obtained after ethics approval and consent from all participants or their family. The total mRNA was isolated using the TRIzol Reagent (Gibcol, Grand Island, USA.) according to the manufacturer's instructions. Reverse transcription was performed using random primers (1 ¦ÌL, 0.2 mg/mL; Sangon company, Shanghai, China) and 1 ¦ÌL Moloney murine leukemin virus (MMLV) Reverse Transcriptase (10 U /¦ÌL, Promega, Madison, USA) in a 15 ¦ÌL reaction mixture. Then RT-PCR was carried out to determine the expression of Ap2¦Â-NY and Ap2¦Â in subjects mentioned above. The primer-pairs used respectively were p1, p2 and p5, p6, which are also specific to Ap2¦Â and its sequence is: P5 5' ATGTGGGAGGTGGATAGGTC 3' and p6 5' ATGGGTTGGCTCAGTCAGG 3'. The desired fragment for Ap2¦Â is 283 bp. The resulting PCR products were identified by 1 % agarose gel electrophoresis and the expression level was analyzed.
4 Discussion
In the present study, a novel isoform of the
Ap2¦Â gene, named Ap2¦Â-NY, was identified. Previously the
Ap2¦Â subunit was found in human fibroblast, rat
lymphocyte, bovine lymphocyte, rat brain and bovine
brain [4]. In the rat brain there was a 42 bp insert in the
coding region, which was thought to be a result of
alternative splicing of the Ap2¦Â subunit [16]. This evidence
reminds us that there may be a different splicing isoform
of Ap2¦Â in human tissue. Indeed, two promoters,
located at -2300 and -1200 bp were found in the upstream
of Ap2¦Â using Promoter 2.0 (Position Score Likelihood
was 1.101 and 1.112, respectively, highly likely prediction). In the present study, we further validated
that Ap2¦Â-NY was expressed in several human
tissues. In testes, Ap2¦Â-NY showed a developmental
stage-dependent expression pattern. It was highly expressed in
adult, spermatogenesis-active testes, but weakly in
embryo and senile testes, suggesting its localization in
spermatogenic cells and its relationship with spermatogenesis.
Our further PCR analysis of infertile patients confirmed
this. Ap2¦Â-NY was not expressed in SCOS, but
disordered in those of spermatogenic disturbances and
spermatogenesis-arrest. Ap2¦Â-NY was indicated to be a newly
found regulator of spermatogenesis in male germ cells.
4.1 Hypothetic traffic model mediated by
Ap2¦Â-NY in testes
Bioinformatical analysis provides some information
regarding the function of Ap2¦Â-NY in spermatogenesis.
SMART analysis showed that Ap2¦Â-NY contained all the
three motifs of Ap2¦Â and is 57 amino acids shorter in the
N-terminal region than Ap2¦Â. The deleted region is
hydrophilic and likely exposed on the surface of the protein,
which, in general, was the position of protein interacting
with others. Deletion of this region may have an
influence on the capability of Ap2¦Â binding with these cargo
molecules, leading to an even greater default of binding.
In embryo testes, Ap2¦Â was predominant. It can
transduce signals into cells by linking cargo proteins and
clathrin. While in adult testes, Ap2¦Â-NY was increas
ingly expressed. It was shortened in trunk domain, which
may result in decreasing affinity with cargo protein in
adaptin. Consequently, the endocytosis of cargo
proteins was curtailed. These cargo proteins, such as
TGF¦Â receptor (TGF¦ÂR) and BubR1, are capable of regulating
cell proliferation and differentiation, and thus affecting
testicular development and spermatogenesis (Figure 8).
Spermatogenesis begins at puberty so there may be
some growth inhibitory mechanism to prevent prepubertal spermatogenic cell proliferation.
TGF¦Â is generally considered as a potent growth inhibitor and
differentiation factor [17-19]. It has recently been revealed by
Ingman that members of the transforming growth factor beta
(TGF¦Â1, TGF¦Â2 and TGF¦Â3) play a key role in
testicular development and spermatogenesis. It is
responsible for the appropriate development and
prevention of premature onset of spermatogenesis [20].
TGF¦Â reduced the number of gonocytes cultured
in vitro by increasing apoptosis [21]. Yao
et al. have proved that an N-terminal trunk domain of
Ap2¦Â was the only direct binding site of
TGF¦ÂR. Shortened regions in the trunk domain may reduce the affinity of
Ap2¦Â with TGF¦ÂR. Fewer quantity of
TGF¦ÂR could be transported into the cytoplasm. Accordingly, the inhibitory effect of
TGF¦Â on gametogenesis was weakened, and at the same time
spermatogenesis started. Although much attention was
paid to the signal transduction of TGF, the mechanism is
still unclear. Here, the existence of Ap2¦Â splicing variant
may, to some extent, shed light on how the signal of
TGF is down-regulated not only in testes but also in other
tissues containing Ap2¦Â-NY. Of course more evidence
is needed to support the hypothesis. In addition, the
trunk domain of Ap2¦Â was also the only binding site of
mitotic checkpoint kinase BubR1 and Bub, both of which
participate in the regulation of cell division [22]. It is
suggested that Ap2¦Â and its new isoform,
Ap2¦Â-NY, regulate the transportation of some other signal proteins in
male gametogenesis. The disordered expression of
Ap2¦Â-NY in infertile patients also indicated its function in
gametogenesis. Further investigation on the isoform of
Ap2¦Â should be valuable to elucidating the mechanism of
spermatogenesis and infertile disease.
In summary, there is a novel splicing isoform of
Ap2¦Â, Ap2¦Â-NY, in human testes. With regard to
Ap2¦Â and its cargos such as TGF¦Â and BubR1, the splicing
isoform Ap2¦Â-NY may, cooperating with
Ap2¦Â, regulate the transportation of signal proteins and thus play an
important role in spermatogenesis and testicular
development.
Acknowledgment
This work was supported by grants from China National 973 (No. G1999055901), National Natural Science
Fundation of China (No. 30425006), the Fundation of
Science and Technology of Jiangsu Province, China (No.
BG2003028) and the Foundation of National Department
of Science and Technology, China (No. 2004CCA06800).
References
1 Druck T, Gu Y, Prabhala G, Cannizzaro LA, Park SH, Huebner
K, Keen JH. Chromosome localization of human genes for
clathrin adaptor polypeptides AP2 beta and AP50 and the
clathrin-binding protein, VCP. Genomics 1995; 30: 94-7.
2 Traub LM. Clathrin-associated adaptor proteins putting it all
together. Trends Cell Biol 1997; 7: 43-6.
3 Hirst J, Robinson MS. Clathrin and adaptors. Biochim Biophys
Acta 1998; 1404: 173-93.
4 Kirchhausen T, Nathanson KL, Matsui W, Vaisberg A, Chow
EP, Burne C, et al. Structural and functional division into two
domains of the large (100- to 115-kDa) chains of the
clathrin-associated protein complex AP2. Proc Natl Acad Sci USA
1989; 86: 2612-6.
5 Owen DJ, Vallis Y, Noble ME, Hunter JB, Dafforn TR, Evans
PR, et al. A structural explanation for the
binding of multiple ligands by the alpha-adaptin appendage domain. Cell 1999;
97: 805-15.
6 Traub LM, Downs MA, Westrich JL, Fremont DH. Crystal
structure of the alpha appendage of AP-2 reveals a recruitment
platform for clathrin-coat assembly. Proc Natl Acad Sci USA
1999; 96: 8907-12.
7 Dell'Angelica EC, Klumperman J, Stoorvogel W, Bonifacino
JS. Association of the AP-3 adaptor complex with clathrin.
Science 1998; 280: 431-4.
8 ter Haar E, Harrison SC, Kirchhausen T. Peptide-in-groove
interactions link target proteins to the beta-propeller of clathrin.
Proc Natl Acad Sci USA 2000; 97: 1096-100.
9 Shih W, Gallusser A, Kirchhausen T. A clathrin-binding site in
the hinge of the beta 2 chain of mammalian AP2 complexes. J
Biol Chem 1995; 270: 31083-90.
10 Ohno H, Stewart J, Fournier MC, Bosshart H, Rhee I,
Miyatake S, et al. Interaction of tyrosine-based sorting signals
with clathrin-associated proteins. Science 1995; 269: 1872- 5.
11 Owen DJ, Evans PR. A structural explanation for the
recognition of tyrosine-based endocytic signals. Science 1998; 282:
1327-32.
12 Rapoport I, Chen YC, Cupers P, Shoelson SE, Kirchhausen T.
Dileucine-based sorting signals bind to the beta Chain of AP-1
at a site distinct and regulated differently from the
tyrosine-based motif-binding site. EMBO J 1998; 17: 2148-55.
13 Yao D, Ehrlich M, Henis YI, Leof EB. Transforming growth
factor-beta receptors interact with AP2 by direct binding to
beta2 subunit. Mol Biol Cell 2002; 13: 4001-12.
14 Sha JH, Zhou ZM, Li J, Yin L, Yang HM, Hu GX,
et al. Identification of testis development and
spermatogenesis-related genes in human and mouse testis using cDNA arrays.
Mol Hum Reprod 2002; 8: 511-7.
15 Wang H, Zhou Z, Xu M, Li J, Xiao J, Xu ZY,
et al. A spermatogenesis-related gene expression profile in human
spermatozoa and its potential clinical applications. J Mol Med 2004;
82: 317-24.
16 Ponnambalam S, Robinson MS, Jackson AP, Peiperl L, Parham
P. Conservation and diversity in families of coated vesicle
adaptins. J Biol Chem 1990; 265: 4814-20.
17 Sporn MB, Roberts AB, Wakefield LM, Assoian RK.
Transforming growth factor-beta: biological function and chemical
structure. Science 1986; 233: 532-4.
18 Barnard JA, Lyons RM, Moses HL. The cell biology of
transforming growth factor beta. Biochim Biophys Acta 1990; 1032:
79-87.
19 Moses HL, Yang EY, Pientpol JA. TGF-beta stimulation and
inhibition of cell proliferation. New mechanistic insights. Cell
1990; 63: 245-7.
20 Ingman WV, Robertson SA. Defining the actions of
transforming growth factor beta in reproduction. Bioessays 2002;
24: 904-14.
21 Olaso R, Pairault C, Boulogne B, Durand P, Habert R.
Transforming growth factor beta1 and beta2 reduce the number of
gonocytes by increasing optosis. Endocrinology 1998; 139:
733-40.
22 Cayrol C, Cougoule C, Wright M. The beta2-adaptin clathrin
adaptor interacts with the mitotic checkpoint kinase BubR1.
Biochem Biophys Res Commun 2002; 298: 720-30.
23 Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P.
Molecular Biology of the Cell. Hamden: Garland Science; 2002. |